References
- Kollberg P, Almquist H, Blackberg M, et al. [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography response evaluation can predict histological response at surgery after induction chemotherapy for oligometastatic bladder cancer. Scand J Urol. 2017 [May 22];[1?6]. [Epub ahead of print]. doi: 10.1080/21681805.2017.1321579
- Bellmunt J, Petrylak DP. New therapeutic challenges in advanced bladder cancer. Semin Oncol. 2012;39:598–607.
- Meijer RP, Mertens LS, van Rhijn BW, et al. Induction chemotherapy followed by surgery in node positive bladder cancer. Urology. 2014;83:134–139.
- Jensen JB, Ulhøi BP, Jensen KM. Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer. Scand J Urol Nephrol. 2011;45:436–443.
- Mertens LS, Fioole-Bruining A, van Rhijn BW. FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer. J Urol. 2013;189:1687–1691.
- Witjes A, Lebret T, Comperat EM, et al. Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71:462–475.